1. Home
  2. CPSS vs ELDN Comparison

CPSS vs ELDN Comparison

Compare CPSS & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPSS
  • ELDN
  • Stock Information
  • Founded
  • CPSS 1991
  • ELDN 2004
  • Country
  • CPSS United States
  • ELDN United States
  • Employees
  • CPSS N/A
  • ELDN N/A
  • Industry
  • CPSS Finance: Consumer Services
  • ELDN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPSS Finance
  • ELDN Health Care
  • Exchange
  • CPSS Nasdaq
  • ELDN Nasdaq
  • Market Cap
  • CPSS 193.8M
  • ELDN 178.4M
  • IPO Year
  • CPSS 1992
  • ELDN N/A
  • Fundamental
  • Price
  • CPSS $9.77
  • ELDN $3.50
  • Analyst Decision
  • CPSS
  • ELDN Strong Buy
  • Analyst Count
  • CPSS 0
  • ELDN 2
  • Target Price
  • CPSS N/A
  • ELDN $12.50
  • AVG Volume (30 Days)
  • CPSS 23.3K
  • ELDN 714.2K
  • Earning Date
  • CPSS 07-29-2025
  • ELDN 08-18-2025
  • Dividend Yield
  • CPSS N/A
  • ELDN N/A
  • EPS Growth
  • CPSS N/A
  • ELDN N/A
  • EPS
  • CPSS 0.79
  • ELDN N/A
  • Revenue
  • CPSS $188,776,000.00
  • ELDN N/A
  • Revenue This Year
  • CPSS $146.82
  • ELDN N/A
  • Revenue Next Year
  • CPSS $18.24
  • ELDN N/A
  • P/E Ratio
  • CPSS $12.32
  • ELDN N/A
  • Revenue Growth
  • CPSS N/A
  • ELDN N/A
  • 52 Week Low
  • CPSS $7.99
  • ELDN $2.38
  • 52 Week High
  • CPSS $12.73
  • ELDN $5.54
  • Technical
  • Relative Strength Index (RSI)
  • CPSS 58.96
  • ELDN 71.94
  • Support Level
  • CPSS $9.79
  • ELDN $3.30
  • Resistance Level
  • CPSS $10.18
  • ELDN $3.52
  • Average True Range (ATR)
  • CPSS 0.29
  • ELDN 0.19
  • MACD
  • CPSS -0.02
  • ELDN 0.09
  • Stochastic Oscillator
  • CPSS 74.14
  • ELDN 98.36

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: